FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2024/07/070830 [Registered on: 18/07/2024] Trial Registered Prospectively
Last Modified On: 15/07/2024
Post Graduate Thesis  No 
Type of Trial  Interventional 
Type of Study   Other (Specify) [Cosmetics]  
Study Design  Single Arm Study 
Public Title of Study   To Evaluate the Earthsukh Anti-Ageing activity of Ghee Based Balm 
Scientific Title of Study   A Clinical Study to Evaluate the Earthsukh Anti-Ageing activity of Ghee Based Balm on Healthy Human Subjects 
Trial Acronym  NIL 
Secondary IDs if Any  
Secondary ID  Identifier 
CCFT 247/Earthsukh Version 1.0 dated 30 June 2024   Protocol Number 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Dr Robin Chugh 
Designation  Principal Investigator 
Affiliation  CCFT Laboratories  
Address  1st Floor room 3, Skin testing lab , CCFT laboratories, AR multispecialty hospital and research center, Delhi Road

Meerut
UTTAR PRADESH
250002
India 
Phone  7078103723  
Fax    
Email  robinderm25@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Puneet Mittal 
Designation  Clinical Research Consultant 
Affiliation  CCFT Laboratories  
Address  1st Floor room 3, Skin testing lab , CCFT laboratories, AR multispecialty hospital and research center, Delhi Road

Meerut
UTTAR PRADESH
250002
India 
Phone  8937015757  
Fax    
Email  puneetmittal@mgcts.org  
 
Details of Contact Person
Public Query
 
Name  Puneet Mittal 
Designation  Clinical Research Consultant 
Affiliation  CCFT Laboratories  
Address  1st Floor room 3, Skin testing lab , CCFT laboratories, AR multispecialty hospital and research center, Delhi Road


UTTAR PRADESH
250002
India 
Phone  8937015757  
Fax    
Email  puneetmittal@mgcts.org  
 
Source of Monetary or Material Support  
Earthsukh, Silk leaf 4, Villa 1, Al Barari Residence, Dubai 936136, UAE 
CCFT Laboratories, 135, Punjabipura, Delhi Road, Meerut, India 
 
Primary Sponsor  
Name  Earthsukh 
Address  Silk leaf 4, Villa 1, Al Barari Residence, Dubai 936136, UAE 
Type of Sponsor  Pharmaceutical industry-Global 
 
Details of Secondary Sponsor  
Name  Address 
Not Applicable  Not Applicable 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr Robin Chugh   CCFT laboratories  AR multispecialty hospital and research center, 1st Floor room 3, Skin testing lab , CCFT laboratories, Delhi Road
Meerut
UTTAR PRADESH 
7078103723

robinderm25@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
ARMHRC Institutional Ethics Committee  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Healthy Human Volunteers  Healthy Volunteers with Ageing effects 
 
Intervention / Comparator Agent  
Type  Name  Details 
Intervention  Ghee Based Balm  Dose: Apply half a pump over the full face with a finger in an outward manner. Duration- once a day at night. Route of administration- Topical  
Comparator Agent  Not Applicable  Not Applicable 
 
Inclusion Criteria  
Age From  40.00 Year(s)
Age To  60.00 Year(s)
Gender  Both 
Details  1) Gender: Non-pregnant, non-lactating female aged between 40 to 60.
2) Subjects willing to give written informed consent
3) Women of childbearing potential must have a negative urine pregnancy test before study entry.
4) Are free of any systemic or dermatologic disorder, which, in the opinion of the investigator, will interfere with the study results or increase the risk of adverse events.
5) Are willing to avoid prolonged exposure of the treatment area to ultraviolet radiation (natural or artificial) for the duration of the study.
 
 
ExclusionCriteria 
Details  1. Subjects who are pregnant, breastfeeding, or planning to become pregnant during the study.
2. Have any evidence of systemic cancer, squamous cell carcinoma, basal cell carcinoma, in the last 5 years, or any other confounding skin condition.
3. Have open sores or open lesions in the treatment area(s).
4. Have any condition that, in the opinion of the investigator, would confound the safety and/or efficacy assessments of the product.
5. Have participated in any interventional clinical trial in the previous 30 days.
6. Have a known sensitivity to any of the constituents of the test product
7. Have used, are using, or are planning to use immunosuppressive or immunomodulatory medication (i.e., biologics), including corticosteroids.
8. Have a history of alcohol or illegal drug/substance abuse, or suspected alcohol or illegal drug/substance abuse in the past 2 years.
 
 
Method of Generating Random Sequence   Not Applicable 
Method of Concealment   Not Applicable 
Blinding/Masking   Open Label 
Primary Outcome  
Outcome  TimePoints 
Change in Skin moisturization, Elasticity, Melanin content, Lightness, Firmness, TEWL  Day0, Day15 and Day 28 
 
Secondary Outcome  
Outcome  TimePoints 
To assess the safety and tolerability   Day0, and Day28 
 
Target Sample Size   Total Sample Size="36"
Sample Size from India="36" 
Final Enrollment numbers achieved (Total)= "0"
Final Enrollment numbers achieved (India)="0" 
Phase of Trial   N/A 
Date of First Enrollment (India)   31/07/2024 
Date of Study Completion (India) Date Missing 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Date Missing 
Estimated Duration of Trial   Years="0"
Months="1"
Days="0" 
Recruitment Status of Trial (Global)   Not Yet Recruiting 
Recruitment Status of Trial (India)  Completed 
Publication Details   N/A 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary  
Single-arm clinical study to evaluate the Anti-Ageing Activity of Ghee Based Balm
1. Ghee-Based Balm
The products will be tested on 36 human volunteers.
Assessment would Notice the improvement in Skin brightening, Skin hydration,  Melanin content, and skin Lightness with follow-up visits on Day 0, Day 15, and Day 28.

The study is done as per BIS standard 4011
 
Close